Page last updated: 2024-10-21

urea and Aggressive Systemic Mastocytosis

urea has been researched along with Aggressive Systemic Mastocytosis in 1 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Aggressive Systemic Mastocytosis: A form of systemic mastocytosis in which patients have impaired organ functions due to multifocal infiltrates of pathological MAST CELLS in bone marrow, liver, spleen, gastrointestinal tract, or skeletal system. The cytomorphology shows a low to high grade.

Research Excerpts

ExcerptRelevanceReference
"The majority of gastrointestinal stromal tumors (GIST) harbor constitutively activating mutations in KIT tyrosine kinase."1.62Ripretinib and MEK Inhibitors Synergize to Induce Apoptosis in Preclinical Models of GIST and Systemic Mastocytosis. ( Flynn, DL; García-Valverde, A; Gupta, A; Serrano, C; Singh, J; Smith, BD, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gupta, A1
Singh, J1
García-Valverde, A1
Serrano, C1
Flynn, DL1
Smith, BD1

Other Studies

1 other study available for urea and Aggressive Systemic Mastocytosis

ArticleYear
Ripretinib and MEK Inhibitors Synergize to Induce Apoptosis in Preclinical Models of GIST and Systemic Mastocytosis.
    Molecular cancer therapeutics, 2021, Volume: 20, Issue:7

    Topics: Animals; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Drug

2021